glp-1 agonist mechanism of action Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP1 - Mechanism of Action
Description
Many people taking Ozempic, Wegovy, Mounjaro, Zepbound, or other GLP-1 medications experience reduced appetite, low energy, nausea, or difficulty eating enough protein throughout the day
[DOI] [PMC free article] [PubMed] [Google Scholar] 42.Khan A.S., et al
In the report, two patients on glucagon-like peptide 1 (GLP-1) agonists had significant gastric contents during elective gastroscopy despite adequate fasting
Another patient group who might benefit from treatment with GLP-1R agonists is gastric by-pass patients who increase their alcohol intake after surgery
So the path looks indirect
